(E)-4-(5-hydroxy-1-(4-(4-methylpiperazin-1-yl)phenyl)-2-phenylpent-1-enyl)phenol dihydrochloride

ID: ALA4438589

Chembl Id: CHEMBL4438589

PubChem CID: 155513315

Max Phase: Preclinical

Molecular Formula: C28H34Cl2N2O2

Molecular Weight: 428.58

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3ccc(O)cc3)cc2)CC1.Cl.Cl

Standard InChI:  InChI=1S/C28H32N2O2.2ClH/c1-29-17-19-30(20-18-29)25-13-9-23(10-14-25)28(24-11-15-26(32)16-12-24)27(8-5-21-31)22-6-3-2-4-7-22;;/h2-4,6-7,9-16,31-32H,5,8,17-21H2,1H3;2*1H/b28-27+;;

Standard InChI Key:  ZTABGVCSNBOTNS-JZYARHMISA-N

Associated Targets(Human)

ESRRA Tchem Estrogen-related receptor alpha (573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESRRB Tchem Estrogen-related receptor beta (173 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESRRG Tchem Estrogen-related receptor gamma (587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 428.58Molecular Weight (Monoisotopic): 428.2464AlogP: 4.88#Rotatable Bonds: 7
Polar Surface Area: 46.94Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.90CX Basic pKa: 7.84CX LogP: 4.85CX LogD: 4.53
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.53Np Likeness Score: -0.24

References

1. Kim J, Song J, Ji HD, Yoo EK, Lee JE, Lee SB, Oh JM, Lee S, Hwang JS, Yoon H, Kim DS, Lee SJ, Jeong M, Lee S, Kim KH, Choi HS, Lee SW, Park KG, Lee IK, Kim SH, Hwang H, Jeon YH, Chin J, Cho SJ..  (2019)  Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer.,  62  (4): [PMID:30657313] [10.1021/acs.jmedchem.8b01296]

Source